System And Method For Intelligent Information Gathering And Analysis

Abstract

A system and method for intelligent information gathering and analysis. Information is gathered from a plurality of open sources such as markets, investigations, government databases, internet intelligence, and public records. The gathered information is parsed and linked based on marketplace activities including threats. The parsed and linked information is sent to a database where queries can be applied to produce dossiers on entities. A client may add his own information to enrich a dossier and reports may be made based on the dossiers. Alerts may be generated when certain predefined conditions are met. These alerts can be used to drive various actions.

Description

RELATED APPLICATIONS[0001]This application claims priority to provisional application No. 60 / 632,854 filed Dec. 3, 2004, entitled “Method and System for Evidence and Intelligence Acquisition and Analysis”, the entirety of which is hereby incorporated by reference.COPYRIGHT NOTICE[0002]A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent files or records, but otherwise reserves all copyright rights whatsoever.BACKGROUND OF THE INVENTION[0003]1. Field of the Invention[0004]The invention relates to information collection and analysis and, more particularly, relates to the collection of data from a plurality of distinct sources and linking that information in light of marketplace activity to acquire richer and more detailed information about an entit...

AI Technical Summary

Problems solved by technology

Threats to the marketplace are continuously evolving, becoming more complex and more prevalent.

Counterfeiting is a multi-dimensional problem.

If the goods being sold are drugs, for example, an ingested counterfeit drug may result in serious health consequences.

If the drug is diverted and sold through a different distribution channel than originally intended, the drug may end up in a different country, be sold for below or above market price, be sold in a country without conforming to necessary regulations, and the company manufacturing the drug may lose significant profits and / or be charged with misleading the public in its sales.

If the evidence acquired does not have a certain minimum level of veracity, it may not even be admissible in courts of law.

Other prior art systems receive limited data about an entity from a client but do not supplement such data with information available to the public from open sources.

Such prior art systems are also generally static in that they typically represent a snapshot in time of information gathered about an entity from limited sources.

These systems do not evolve to provide an updated view of an entity as more information is acquired about the entity.

Further, there is no means in the prior art systems for intelligent linking of acquired information.

Images